Medical Devices industry M&A deals total $3.3bn in North America in January 2022

Total medical devices industry M&A deals worth $3.3bn were announced in North America in January 2022, led by Owens & Minor’s $1.6bn acquisition of Apria, according to GlobalData’s deals database.

The value marked a decrease of 91.9% over the previous month of $40.38bn and a drop of 59.4% when compared with the last 12-month average of $8.06bn.

North America held a 99.09% share of the global medical devices industry M&A deal value that totalled $3.3bn in January 2022. With a 98.79% share and deals worth $3.26bn, the US was the top country in North America’s M&A deal value across medical devices industry.

In terms of M&A deal activity, North America recorded 33 deals during January 2022, marking a decrease of 10.81% over the previous month and a rise of 32.00% over the 12-month average. The US recorded 31 deals during the month.

North America medical devices industry M&A deals in January 2022: Top deals

The top five medical devices industry M&A deals accounted for 94.8% of the overall value during January 2022.

The combined value of the top five medical devices deals stood at $3.1bn, against the overall value of $3.3bn recorded for the month.

The top five medical devices industry M&A deals of January 2022 tracked by GlobalData were:

1) Owens & Minor $1.6bn acquisition deal with Apria

2) The $623m acquisition of GeneDX by Sema4 OpCo

3) ConvaTec Group $450m acquisition deal with Triad Life Sciences

4) The $240m acquisition of MyChem by Maravai LifeSciences Holdings

5) Exact Sciences $190m acquisition deal with PreventionGenetics